Ypsomed Holding AGXSWX:YPSN -0.66%92 Gross Margin % is 44.64% as of Mar. 2026, which is 43% above its 10-year median of 31.11. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF397.15 (Fairly Valued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 65.09% on this metric.
The historical rank and industry rank for Ypsomed Holding AG's Gross Margin % or its related term are showing as below:
XSWX:YPSN'
s Gross Margin % Range Over the Past 10 Years
Min: 23.07 Med: 31.11 Max: 43.04
Current: 43.04
During the past 13 years, the highestGross Margin % of Ypsomed Holding AG was 43.04%. The lowest was 23.07%. And the median was 31.11%.
XSWX:YPSN's Gross Margin % is ranked worse than 65.09% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs XSWX:YPSN: 43.04
Ypsomed Holding AG had a gross margin of 44.64% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Ypsomed Holding AG was 14.60% per year.
Ypsomed Holding AG (XSWX:YPSN) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ypsomed Holding AG had a gross margin of 44.64% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Ypsomed Holding AG Gross Margin % Related Terms
Ypsomed Holding AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:YPSN vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ypsomed Holding AG (XSWX:YPSN) has a Gross Margin % of 44.64% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Ypsomed Holding AG and its competitors. This is 43% above median its historical median of 31.11. Over the past decade, Ypsomed Holding AG's Gross Margin % has ranged from 23.07 to 43.04. According to the industry distribution chart, Ypsomed Holding AG ranks #524 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 65.1%.
Is Ypsomed Holding AG's Gross Margin % too high?
Ypsomed Holding AG's current Gross Margin % of 44.64% is 43% above median its 10-year median of 31.11. Over the past 10 years, this metric has ranged from a low of 23.07 to a high of 43.04. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Ypsomed Holding AG's value of 44.64% is 14.3% below this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #524 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #524 out of 805 companies for Gross Margin %. This places Ypsomed Holding AG in the lower half of its industry. The industry median Gross Margin % is 52.07. Ypsomed Holding AG's value of 44.64% is 14.3% below this benchmark. Historically, Ypsomed Holding AG's own Gross Margin % has ranged from 23.07 to 43.04 over the past decade. While the company's 10-year median is 31.11 vs. the industry median of 52.07, Ypsomed Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Gross Margin % of 44.64% is 14.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Gross Margin % is 44.64%, which is 43% above median its own 10-year median of 31.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.15, compared to a current price of CHF360.60 — trading 9.2% below its estimated fair value. The current Gross Margin % is 44.64%, which is 43% above median its 10-year median of 31.11 and 14.3% below the Medical Devices & Instruments industry median of 52.07. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Gross Margin % is 44.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF360.60 is trading 9.2% below its estimated GF Value™ of CHF397.15.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for XSWX:YPSN:
Gross Margin %: 44.64% (43% above median its 10-year median of 31.11)
GF Value™: CHF397.15 vs. price of CHF360.60 (9.2% below fair value)
Industry Position: 14.3% below the Medical Devices & Instruments median (#524 of 805)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score
Get the complete analysis for XSWX:YPSN
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
